Presentation is loading. Please wait.

Presentation is loading. Please wait.

Adrenergic agemts.

Similar presentations


Presentation on theme: "Adrenergic agemts."— Presentation transcript:

1 Adrenergic agemts

2 Learning Objectives Understand the central and peripheral nervous systems, their functions, and their relationship to drugs. Become aware of the role of neurotransmitters. Learn how adrenergic drugs affect body systems and where they work in the body.

3 Learning Objectives Define the action of neuromuscular blocking agents in reducing muscle activity. Distinguish between narcotic and nonnarcotic analgesia. Become familiar with the various types of agents for migraine headaches.

4 Divisions of the Nervous System
Central Nervous System Brain Spinal cord Peripheral Nervous System Nerves Sense organs

5 Divisions of the Nervous System
Central Nervous System Peripheral Nervous System

6 Divisions of the Nervous System
Central Nervous System Peripheral Nervous System Somatic Nervous System Autonomic Nervous System

7 Divisions of the Nervous System
Central Nervous System Peripheral Nervous System Somatic Nervous System Voluntary action: skeletal muscle contraction and movement Autonomic Nervous System Involuntary activities: respiration, circulation, digestion, sweating

8 Autonomic Nervous System

9 Review The nervous system has two components. What are they?

10 Review Answer Central nervous system (CNS)
The nervous system has two components. What are they? Answer Central nervous system (CNS) Peripheral nervous system (PNS)

11 Major Neurotransmitters
Acetylcholine GABA Dopamine Epinephrine Serotonin

12 Major Neurotransmitters
Acetylcholine (ACh) Smooth muscle, cardiac muscle, and exocrine glands Anticholinergics block ACh receptors GABA Dopamine Epinephrine Serotonin

13 Major Neurotransmitters
Acetylcholine GABA (gamma-aminobutyric acid) Regulates message delivery system of the brain Dopamine Epinephrine Serotonin

14 Major Neurotransmitters
Acetylcholine GABA Dopamine Acts on the CNS and kidneys Epinephrine Serotonin

15 Major Neurotransmitters
Acetylcholine GABA Dopamine Epinephrine Acts on cardiac and bronchodilator receptors Known as Adrenaline Serotonin

16 Major Neurotransmitters
Acetylcholine GABA Dopamine Epinephrine Serotonin Acts on smooth muscle and gastric mucosa (causes vasoconstriction) Emotional responses: depression, anxiety

17 Communication by Neurotransmitters
Neurotransmitters are released from one axon and received by another neuron’s dendrites.

18 Discussion What are three important types of receptors in the study of drugs?

19 Discussion Answer Alpha Beta-1 Beta-2
What are three important types of adrenergic receptors in the study of drugs? Answer Alpha Beta-1 Beta-2

20

21 Types of Receptors Alpha Beta-1 Beta-2 Vasoconstriction, raise BP
Heart stimulation Beta-2 Vasodilation and bronchodilation

22 Drugs Affecting The Autonomic Nervous System
Adrenergic Agents and Adrenergic-Blocking Agents

23 The Sympathetic Nervous System in Relationship to the Entire Nervous System

24 Adrenergic Agents Drugs that stimulate the sympathetic nervous system (SNS)

25 Adrenergic Agents Also known as
adrenergic agonists or sympathomimetics

26 Adrenergic Agents Mimic the effects of the SNS neurotransmitters:
norepinephrine (NE) and epinephrine (EPI)

27 Adrenergic Receptors Located throughout the body
Are receptors for the sympathetic neurotransmitters Alpha-adrenergic receptors: respond to NE Beta-adrenergic receptors: respond to EPI

28 Alpha-Adrenergic Receptors
Divided into alpha1 and alpha2 receptors Differentiated by their location on nerves

29 Alpha1-Adrenergic Receptors
Located on postsynaptic effector cells (the cell, muscle, or organ that the nerve stimulates)

30 Alpha2-Adrenergic Receptors
Located on presynaptic nerve terminals (the nerve that stimulates the effector cells) Control the release of neurotransmitters

31 The predominant alpha-adrenergic agonist responses are:
Vasoconstriction and CNS stimulation

32 Beta-Adrenergic Receptors
All are located on postsynaptic effector cells Beta1-adrenergic receptors—located primarily in the heart Beta2-adrenergic receptors—located in smooth muscle of the bronchioles, arterioles, and visceral organs

33 The beta-adrenergic agonist response results in:
Bronchial, GI, and uterine smooth muscle relaxation Glycogenolysis Cardiac stimulation

34 Dopaminergic Receptors
An additional adrenergic receptor Stimulated by dopamine Causes dilation of the following blood vessels, resulting in INCREASED blood flow Renal Mesenteric Coronary Cerebral

35 Adrenergic Receptor Responses to Stimulation
LOCATION RECEPTOR RESPONSE Cardiovascular Blood vessels alpha1 and beta2 Constriction / dilation Cardiac muscle beta1 Increased contractility AV Node beta1 Increased heart rate SA Node beta1 Increased heart rate

36 Adrenergic Receptor Responses to Stimulation
LOCATION RECEPTOR RESPONSE Gastrointestinal Muscle beta2 Decreased motility Sphincters alpha1 Constriction

37 Adrenergic Receptor Responses to Stimulation
LOCATION RECEPTOR RESPONSE Genitourinary Bladder alpha1 Constriction sphincter Penis alpha1 Ejaculation Uterus alpha1 and beta2 Contraction/ relaxation

38 Adrenergic Receptor Responses to Stimulation
LOCATION RECEPTOR RESPONSE Respiratory Bronchial beta2 Dilation/relaxation muscles

39 Catecholamines Substances that can produce a sympathomimetic response
Endogenous: epinephrine, norepinephrine,dopamine Synthetic: isoproterenol, dobutamine, phenylephrine

40 Adrenergic Agents Mechanism of Action
Direct-acting sympathomimetic: Binds directly to the receptor and causes a physiologic response

41 Direct-Acting Sympathomimetics

42 Adrenergic Agents Mechanism of Action
Indirect-acting sympathomimetic: Causes the release of catecholamine from the storage sites (vesicles) in the nerve endings The catecholamine then binds to the receptors and causes a physiologic response

43 Indirect-Acting Sympathomimetics

44 Adrenergic Agents Mechanism of Action
Mixed-acting sympathomimetic: Directly stimulates the receptor by binding to it AND Indirectly stimulates the receptor by causing the release of stored neurotransmitters from the vesicles in the nerve endings

45 Mixed-Acting Sympathomimetics

46 Drug Effects of Adrenergic Agents
Stimulation of alpha-adrenergic receptors on smooth muscles results in: Vasoconstriction of blood vessels Relaxation of GI smooth muscles Contraction of the uterus and bladder Male ejaculation Decreased insulin release Contraction of the ciliary muscles of the eye (dilated pupils)

47 Drug Effects of Adrenergic Agents
Stimulation of beta2-adrenergic receptors on the airways results in: Bronchodilation (relaxation of the bronchi) Uterine relaxation Glycogenolysis in the liver

48 Drug Effects of Adrenergic Agents
Stimulation of beta1-adrenergic receptors on the myocardium, AV node, and SA node results in CARDIAC STIMULATION: Increased force of contraction (positive inotropic effect) Increased heart rate (positive chronotropic effect) Increased conduction through the AV node (positive dromotropic effect)

49 Adrenergic Agents: Therapeutic Uses
Anorexiants: adjuncts to diet in the short-term management of obesity Examples: benzphetamine phentermine dextroamphetamine Dexedrine

50 Adrenergic Agents: Therapeutic Uses
Bronchodilators: treatment of asthma and bronchitis Agents that stimulate beta2-adrenergic receptors of bronchial smooth muscles causing relaxation Examples: albuterol ephedrine epinephrine isoetharine isoproterenol levalbuterol metaproterenol salmeterol terbutaline These agents may also affect uterine and vascular smooth muscles.

51 Adrenergic Agents: Therapeutic Uses
Reduction of intraocular pressure and mydriasis (pupil dilation): treatment of open-angle glaucoma Examples: epinephrine and dipivefrin

52 Adrenergic Agents: Therapeutic Uses
Nasal decongestant: Intranasal (topical) application causes constriction of dilated arterioles and reduction of nasal blood flow, thus decreasing congestion. Examples: epinephrine ephedrine naphazoline phenylephrine tetrahydrozoline

53 Adrenergic Agents: Therapeutic Uses
Ophthalmic Topical application to the eye surface affects the vasculature of the eye, stimulating alpha receptors on small arterioles, thus relieving conjunctival congestion. Examples: epinephrine naphazoline phenylephrine tetrahydrozoline

54 Adrenergic Agents: Therapeutic Uses
Vasoactive sympathomimetics (pressors, inotropes), also called cardioselective sympathomimetics Used to support the heart during cardiac failure or shock. Examples: dobutamine dopamine ephedrine epinephrine fenoldopam isoproterenol methoxamine norepinephrine phenylephrine

55 Adrenergic Agents: Side Effects
Alpha-Adrenergic Effects CNS: headache, restlessness, excitement, insomnia, euphoria Cardiovascular: palpitations (dysrhythmias), tachycardia, vasoconstriction, hypertension Other: anorexia, dry mouth, nausea, vomiting, taste changes (rare)

56 Adrenergic Agents: Side Effects
Beta-Adrenergic Effects CNS: mild tremors, headache, nervousness, dizziness Cardiovascular: increased heart rate, palpitations (dysrhythmias), fluctuations in BP Other: sweating, nausea, vomiting, muscle cramps

57 Adrenergic Agents: Interactions
Anesthetic agents Tricyclic antidepressants MAOIs Antihistamines Thyroid preparations Antihypertensives Will directly antagonize another adrenergic agent, resulting in reduced effects

58 Adrenergic Agents: Nursing Implications
Assess for allergies and history of hypertension, cardiac dysrhythmias, or other cardiovascular disease. Assess renal, hepatic, and cardiac function before treatment. Perform baseline assessment of vital signs, peripheral pulses, skin color, temperature, and capillary refill. Include postural blood pressure and pulse. Follow administration guidelines carefully.

59 Adrenergic Agents: Nursing Implications
IV administration: Check IV site often for infiltration Use clear IV solutions Use an infusion device/IV pump Infuse agent slowly to avoid dangerous cardiovascular effects Monitor cardiac rhythm

60 Adrenergic Agents: Nursing Implications
With chronic lung disease: Instruct patients to avoid factors that exacerbate their condition. Encourage fluid intake (up to 3000 mL per day) if permitted. Educate about proper dosing and equipment care. Salmeterol is indicated for PREVENTION of bronchospasms, not management of acute symptoms.

61 Adrenergic Agents: Nursing Implications
Overuse of nasal decongestants may cause rebound nasal congestion or ulcerations. Avoid OTC or other medications because of possible interactions. Administering two adrenergic agents together may precipitate severe cardiovascular effects such as tachycardia or hypertension. Inform patients taking inhaled isoproterenol that their sputum or saliva may turn pink.

62 Adrenergic Agents: Nursing Implications
Monitor for therapeutic effects (cardiovascular uses): Decreased edema Increased urinary output Return to normal vital signs Improved skin color and temperature Increased LOC

63 Adrenergic Agents: Nursing Implications
Monitor for therapeutic effects (asthma): Return to normal respiratory rate Improved breath sounds, fewer rales Increased air exchange Decreased cough Less dyspnea Improved blood gases Increased activity tolerance

64 Adrenergic-Blocking Agents
Bind to adrenergic receptors, but inhibit or block stimulation of the sympathetic nervous system (SNS)

65 Adrenergic Blocking Agents
Have the opposite effect of adrenergic agents Also known as adrenergic antagonists or sympatholytics

66 Adrenergic Blocking Agents
Sympatholytics inhibit—or LYSE—sympathetic neurotransmitters (norepinephrine and epinephrine)

67 Adrenergic Blocking Agents
Classified by the type of adrenergic receptor they block Alpha1 and alpha2 receptors Beta1 and beta2 receptors

68 Alpha-Blocker Mechanisms

69 Adrenergic-Blocking Agents: Drug Effects and Therapeutic Uses
Ergot Alkaloids (Alpha-Blockers) Constrict dilated arteries going to the brain (carotid arteries) Used to treat vascular headaches (migraines) Stimulate uterine contractions by inducing vasoconstriction Used to control postpartum bleeding

70 Adrenergic-Blocking Agents: Drug Effects and Therapeutic Uses
Alpha-Blockers Cause both arterial and venous dilation, reducing peripheral vascular resistance and BP Used to treat hypertension Effect on receptors on prostate gland and bladder decreased resistance to urinary outflow, thus reducing urinary obstruction and relieving effects of BPH

71 Adrenergic-Blocking Agents: Drug Effects and Therapeutic Uses
Alpha-Blockers Phentolamine Quickly reverses the potent vasoconstrictive effects of extravasated vasopressors such as norepinephrine or epinephrine. Restores blood flow and prevents tissue necrosis.

72 Adrenergic-Blocking Agents: Side Effects
Alpha Blockers Body System Side/Adverse Effects Cardiovascular Palpitations, orthostatic hypotension, tachycardia, edema, dysrhythmias, chest pain CNS Dizziness, headache, drowsiness, anxiety, depression, vertigo, weakness, numbness, fatigue

73 Adrenergic-Blocking Agents: Side Effects
Alpha Blockers Body System Side/Adverse Effects Gastrointestinal Nausea, vomiting, diarrhea, constipation, abdominal pain Other Incontinence, nose bleeding, tinnitus, dry mouth, pharyngitis, rhinitis

74 Beta Blockers Block stimulation of beta receptors in the SNS
Compete with norepinephrine and epinephrine Selective and nonselective beta blockers

75 Beta Receptors Beta1 Receptors Located primarily on the heart
Beta blockers selective for these receptors are called cardioselective beta blockers

76 Beta Receptors Beta2 Receptors
Located primarily on smooth muscles of bronchioles and blood vessels

77 Nonspecific Beta Blockers
Beta blockers that block both beta1 and beta2 receptors

78 Salbutamol (ventolin)
selective b2-adrenomimetic of direct action Administration inhalations during attacks of bronchial asthma and bronchial spasms of other etiology, передчасних child delivery, бурхливій child delivery

79 Beta Blockers: Mechanism of Action
Cardioselective (Beta1) Decreases heart rate Prolongs SA node recovery Slows conduction rate through the AV node Decreases myocardial contractility, thus decreasing myocardial oxygen demand

80 Beta Blockers: Mechanism of Action
Nonspecific (Beta1 and Beta2) Effects on heart: Same as cardioselective Bronchioles: Constriction, resulting in narrowing of airways and shortness of breath Blood vessels: Vasoconstriction

81

82 Beta Blockers: Therapeutic Uses
Anti-angina: decreases demand for myocardial oxygen Cardioprotective: inhibits stimulation by circulating catecholamines Class II antidysrhythmic

83 Terbutalin (brikanil) and phenoterol (berotek, partusisten)
are stimulants of mostly 2-adrenal receptors. They posses broncholytic and tokolytic activity

84 Beta Blockers: Therapeutic Uses
Antihypertensive Treatment of migraine headaches Glaucoma (topical use)

85 Beta Blockers: Side Effects
Body System Side/Adverse Effects Blood Agranulocytosis, thrombocytopenia Cardiovascular AV block, bradycardia, congestive heart failure, peripheral vascular insufficiency CNS Dizziness, mental depression, lethargy, hallucinations

86 Adrenergic-Blocking Agents: Side Effects
Beta Blockers Body System Side/Adverse Effects Gastrointestinal Nausea, dry mouth, vomiting, diarrhea, cramps, ischemic colitis Other Impotence, rash, alopecia, bronchospasms

87 Adrenergic Blocking Agents: Nursing Implications
Assess for allergies and history of COPD, hypotension, cardiac dysrhythmias, bradycardia, CHF, or other cardiovascular problems Any preexisting condition that might be exacerbated by the use of these agents might be a CONTRAINDICATION to their use.

88 Adrenergic Blocking Agents: Nursing Implications
Remember that alpha blockers may precipitate hypotension. Remember that beta blockers may precipitate bradycardia, hypotension, heart block, CHF, and bronchoconstriction.

89 Adrenergic Blocking Agents: Nursing Implications
Avoid OTC medications because of possible interactions. Possible drug interactions may occur with: Antacids (aluminum hydroxide type) Antimuscarinics/anticholinergics Diuretics and cardiovascular drugs Neuromuscular blocking agents Oral hypoglycemic agents

90 Adrenergic Blocking Agents: Nursing Implications
Encourage patients to take medications as prescribed. These medications should never be stopped abruptly. Report constipation or the development of any urinary hesitancy or bladder distention.

91 Adrenergic Blocking Agents: Nursing Implications
Teach patients to change positions slowly to prevent or minimize postural hypotension. Avoid caffeine (excessive irritability). Avoid alcohol ingestion and hazardous activities until blood levels become stable. Patients should notify their physician if palpitations, dyspnea, nausea, or vomiting occur.

92 Beta Blocking Agents: Nursing Implications
Rebound hypertension or chest pain may occur if this medication is discontinued abruptly. Patients should notify their physician if they become ill and unable to take medication. Inform patients that they may notice a decrease in their tolerance for exercise; dizziness and fainting may occur with increased activity. Notify the physician if these problems occur.

93 Beta Blocking Agents: Nursing Implications
Patients should report the following to their physician: Weight gain of more than 2 pounds (1 kg) within a week Edema of the feet or ankles Shortness of breath Excessive fatigue or weakness Syncope or dizziness

94 Adrenergic Blocking Agents: Nursing Implications
Monitor for side effects, including: Hypotension Fatigue Tachycardia (alpha blockers) Lethargy Bradycardia Depression Heart block Insomnia CHF Vivid nightmares Increased airway resistance

95 Adrenergic Blocking Agents: Nursing Implications
Monitor for therapeutic effects Decreased chest pain in patients with angina Return to normal BP and P Other specific effects, depending on the use

96 б) adrenomimetics of indirect action or sympathomimetics
а) adrenomimetics of direct action б) adrenomimetics of indirect action or sympathomimetics Adrenoblockers or adrenolytics Sympatholytics

97 І. Adrenomimetics - і -adrenomimetics (adrenalin hydrochloride, noradrenalin hydrotartrate) 2. dopamine-, -, -adrenomimetics (dopamine) 3. -adrenomimetics (mesatone, naftizin, galazoline) 4. -adrenomimetics (isadrine, salbutamol, phenoterol, terbutalin, dobutamine) ІІ. Sympathomimetics (ephedrine hydrochloride) ІІІ. Adrenoblockers 1. -adrenoblockers (phentolamine, tropaphen, prasosine, pyroxan) 2. -adrenoblockers (anaprilin, athenolol, talinolol, acebutolol) 3. - і -adrenoblockers (labetalol) ІІІ. Sympatholytics (reserpine, octadine)

98 Adrenomimetcs

99

100 adrenaline hydrochloride Administration
Adrenalin (epinephrine) is a hormone of medullar layer of adrenal glands which is used in a form of a remedy adrenaline hydrochloride It is an adrenomimetic which stimulates 1,- 2- and 1,- 2-adrenoreceptors Administration sudden stoppage of heart, for example, during surgical narcosis electric trauma shock and collapse conditions bronchial spasm hypoglycemic coma treatment of open-angle glaucoma

101

102 Noradrenalin hydrotartrate (norepinephrine)
Is an adrenomimetic of direct action which stimulates 1-, 2- and 1-adrenal receptors Administration in cases of acute decreasing of blood pressure - shock and collapse conditions, surgeries, traumas The drug is absolutely contraindicated for subcutaneous and intramuscular introductions

103 Dopamine shock and collapse Drug of choice for treatment of
of different etiology, including cardiogenic and hemorrhagic

104 Mesaton (phenilefrin)
Is a synthetic a1-adrenomimetic drug of direct action Administration acute hypotensive conditions, prophylaxis of decreasing of blood pressure in case of infectious diseases, poisonings, decreasing of blood pressure during narcosis with fluorothan and cyclopropan nose drops in case of rhinits

105 Naphtisin Xylometazolin
are a2-adrenomimetics of direct action Usage for rhinitis in a form of nose drops – 1-2 drops 2-3 times a day It is not recommended to use the drug in case of chronic cold

106

107 Isadrin (isoprenalin, novodrin, euspiran)
– is a synthetic catecholamine, which is a strong stimulant of b1- і b2-adrenal receptors Administration bradycardia, atrio-ventricular blockade bronchial spasm complex therapy of some kinds of shock (if the patient doesn’t have hypovolemia) Side effects nausea, hands tremor, dryness in mouth, in patients with ischemic heart disease – attack of stenocardia, heavy cardiac tachyarrhythmias, even fibrillation of ventricles

108 Salbutamol (ventolin)
selective b2-adrenomimetic of direct action Administration inhalations during attacks of bronchial asthma and bronchial spasms of other etiology, передчасних child delivery, бурхливій child delivery

109 Terbutalin (brikanil) and phenoterol (berotek, partusisten)
are stimulants of mostly 2-adrenal receptors. They posses broncholytic and tokolytic activity

110 Dobutamin Administration Is a synthetic 1-adrenomimetic
Cardiotonic effects of dobutamin is 5 times stronger than action of dopamine Administration some forms of acute and chronic cardiac insufficiency intravenous dropping infusion with the speed of 2,5-10 mcg / (kg.min)

111 Sympathomimetics

112 Ephedrine hydrochloride (Ephedrini hydrochloridum)
It is an alkaloid of plants of Ephedra family, which has indirect a-, b-adrenomimetic (sympathomimetic) action Administration collapse conditions, for prophylaxis of decreasing of blood pressure before spinal anesthesia, infectious diseases treatment of rhinitis (2 %, 3 % solution to drop into nose). prophylaxis and elimination of bronchial spasm (inhalations 0,5 %-1 % solutions of drug) SIDE EFFECTS неспокій, excitement, tremor, inconsiderable euphoria, insomnia, seizures drug addiction tachyphylaxy

113 Adrenoblockers

114 Alfa-adrenoblockers

115 Phentolamine, tropaphen
are synthetic a1, 2-аdrenoblockers administration diagnostics and symptomatic treatment of feochromocytoma disturbances of peripheral blood circulation in case of endarteritis, Reino’s disease, trophic ulcers, decubitus complex treatment of hypertensive crises, acute cardiac insufficiency complex therapy of hypovolemic and cardiogenic shock

116 Selective a1- adrenoblocker
Prasosin Selective a1- adrenoblocker Administration treatment of essential hypertension stabile cardiac insufficiency Side effects “phenomenon of first dose”: sudden decreasing of blood pressure and even development of orthostatic collapse after first administrations of the drug Prophylaxis: administration of half-dose before sleep

117 Beta-adrenoblockers

118 Anaprilin Administration essential hypertension
Is a selective b1- і b2-adrenoblocker Administration ischemic heart disease essential hypertension cardiac tachyarrhythmias acute myocardium infarction

119

120

121 Talinolol or cordanum Administration is a cardioselective
b-adrenoblocker Administration disorders of cardiac rhythm (extrasystolies, paroxysmal tachycardia, fibrillation and scintillation of atria) stenocardia arterial hypetension .

122 Atenolol (tenormin) essential hypertension cardiac arrhythmias
cardioselelctive -adrenoblocker of long action Indications for administration ischemic heart disease essential hypertension cardiac arrhythmias acute myocardium infarction

123 1-adrenoblocker with internal sympathomimetic activity
Acebutolol (sectral) 1-adrenoblocker with internal sympathomimetic activity Indications disorders of cardiac rhythm (tachyarrhythmias) hypertension ischemic heart disease

124 Labetolol Contraindications
-, -adrenoblocker. The drug blocks 1, 2, 1 and 2-adrenoreceptors Administration treatment of patients with essential hypertension hypertensive crisis Contraindications Atrio-ventricular blockade, cardiac insufficiency

125 Sympatholytics

126 Reserpin Administration Side effects manifestations of parkinsonism
is a sum of раувольфії (plant) alkaloids. Maximal hypotensive action develops after 5-7 days of regular administration of the drug. After the treatment coarse effect can still stay for two weeks. Administration treatment of different forms of essential hypertension (combined drugs trirezid, cristepin, adelfan, brinerdin) Side effects manifestations of parkinsonism в’ялість, somnolence, depression, bradycardia increasing of motor and secretory activity of gastro-intestinal tract, acute attacks of ulcer disease, diarrhea swelling of nose mucous membrane with complication of nose breathing

127 Octadin Is a sympatholytic with strong hypotensive effect. During administration of the drug decreasing of blood pressure develops gradually, after 2-3 days. After quitting of drug administration the effect still stays for 2 weeks. Administration heavy forms of arterial hypertension Side effects general weakness, nausea, vomiting, swelling of nose mucous membrane, diarrhea, storing of liquid in the organism, orthostatic collapse.

128 Thanks for attention!


Download ppt "Adrenergic agemts."

Similar presentations


Ads by Google